Category Archives: Uke 17

Reflections on an Exciting Journey at K2

As my time as the Head of K2 comes to an end, I feel both nostalgia and gratitude. These past six years have been a whirlwind of challenges, triumphs, and camaraderie – a journey that has left deep marks on our department.

A Pattern of Outstanding Achievements

Our department is like a vibrant pattern woven from various disciplines. From medical education to pharmacy and nutrition, we have nurtured the minds of countless students, shaped their futures, and instilled in them a high standard of quality. Our professors and associate professors – 52 steadfast individuals in permanent positions and 79 dedicated souls in part-time roles – form the threads of this network, enabling us to provide our students with education that will carry them safely into their professional lives.

The unsung heroes

But let us not forget the less visible heroes – the 171 doctoral and postdoctoral researchers who tirelessly work in the laboratories, unravel mysteries, and push the boundaries of knowledge. Their passion drives our research, and their curiosity propels us forward. To them, I extend my deepest gratitude.

Groundbreaking Discoveries

Our journey has been marked by milestones. We have stood on local podiums, received well-deserved awards, and national and international recognition has affirmed our collective efforts. We have contributed to groundbreaking discoveries why our research graces the pages of prestigious international journals, including the Nature family.

The magic of translation

Our research is more than data points – it is a bridge between the laboratory and the hospital bed. Always keeping the patient in mind, we work toward solutions that matter. And it is this delicate balance between science and practice, between molecules and medicine, that ultimately turns hypotheses into hope – into improved diagnostics and treatment for our patients.

Facing the storms

Yes, there have been storms. The COVID-19 pandemic and economic challenges have tested our resilience. But like seasoned sailors, we have adjusted our sails and navigated through turbulent waters. And amidst it all, the spirit of K2 remains unwavering – a beacon of collaboration.

Gratitude prevails

Today, as I stand at the threshold of a new chapter, my heart is filled primarily with gratitude. To the technicians fine-tuning our instruments, the young researchers dreaming big, and the professors sparking curiosity. And let us not forget the unsung heroes – the administrative warriors who keep our ship afloat. Their precise work may go unnoticed, but it is always deeply appreciated. Thanks a lot.


As I pen my final editorial comment, I raise a virtual glass to each one of you. Our institute is not just about science; it is about people – the beating hearts that breathe life into the walls of K2’s many rooms. My hope is that K2 continues to flourish, bringing joy to new generations.

A thousand thanks, dear colleagues, for making this journey unforgettable. We will meet again, albeit with me in a different role.


New calls in the Horizon Europe Cancer Mission:

The European Commission has now announced six new calls for funding under the Cancer Mission. The following two are particularly relevant for researchers at The Faculty of Medicine:

Accessible and affordable tests to advance early detection of heritable cancers in European regions
 HORIZON-MISS-2024-CANCER-01-03. Innovation action 12 MIO EUR per project. To validate easy-to-use, affordable and accessible genetic, multi-omics or other biomarker-based cancer tests for early detection of cancers with an underlying heritable genetic risk. Activities are expected to achieve TRL 5 to 7 by the end of the project. ​​​​​​​

Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer HORIZON-MISS-2024-CANCER-01-05. 6 MIO EUR per project. The focus should be exclusively on adolescent and young adult (AYA, age range 15-39) cancer patients and survivors.

Application Deadline: 18 September 2024 

 If these topics sound interesting, please contact the research advisers at MED for advise on how to build or join a consortium and apply: Application Support for External Funding | Faculty of Medicine | UiB

 You can also join the EU Info Days on 25 and 26 April to learn more about the calls: Events | The research and innovation community platform (

From breakthrough technologies to game changing innovations – EIC Opportunities

The programme for the May 7th EIC- seminar has been updated. Please find the updated programme and schedule attached.

Note, the duration of the program has been extended from 12:00 to 14:30.

Where: Digital and The Research Council of Norway, Drammensveien 288, Lysaker
Target group: Researchers, companies, TTO, research leaders, research and innovation administrators, EU advisors and innovation advisors
Registration deadline for in-person participation: Thursday, May 2 at 23:00
Registration deadline for digital participation: Monday, May 6 at 23:00
Digital: Live streaming
7 May 08:30–14:30

Final Program_Updated_EN

Disputation – Alexander Vietheer | May 3rd 2024

Trial lecture: May 3, 2024, at 10:15 AM

Location: Auditorium, Glasblokkene 2, block 8 Topic: “Human fetal growth restriction: pathophysiology, consequences, and treatment in high and low-income countries”

Photo/Illustration: Nina Vietheer

Public Defense: May 3, 2024, at 12:15 PM

Location: Auditorium, Glasblokkene 2, block 8 Thesis Title: “Human Embryonic Development: Effects of Physical Activity and Sleep in Physiological Pregnancies”

1. Opponent: Professor Kaarin Mäkikallio, Turku University Hospital, Finland
2. Opponent: PhD Vasilis Sitras, Oslo University Hospital
3. Committee member: Professor Sven Gudmund Hinderaker, University of Bergen

The defense will be chaired by Professor Nils-Halvdan Morken.

Open to all interested parties

Press Release (Only Norwegian)

Disputas – Ingrid G. Rekeland | May 2nd 2024

Sample lecture: Thursday, May 2, 2024, at 10:15 AM

Location: Auditorium, Armauer Hansen House, Haukelandsveien 28 Topic: “Long-covid-19: Diagnosis, Epidemiology, Pathophysiology, and Treatment Options”

Photo/Illustration: Private

Defense: Thursday, May 2, 2024, at 12:15 PM

Location: Auditorium, Armauer Hansen House, Haukelandsveien 28 Thesis Title: “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Clinical Trials, Medical Treatment, and Pathomechanisms”

1. Opponent: Professor Per Ole Iversen, University of Oslo
2. Opponent: Associate Professor Rasmus Goll, UiT, The Arctic University of Norway
3. Committee Member: Associate Professor Bettina Riedel, University of Bergen

The defense will be chaired by Professor Camilla Tøndel.

Open to all interested parties

Press Release (Only Norwegian)